Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study
Source abstract
Abstract
Carbon nanotubes have distinctive characteristics, but their needle-like fibre shape has been compared to asbestos, raising concerns that widespread use of carbon nanotubes may lead to mesothelioma, cancer of the lining of the lungs caused by exposure to asbestos. Here we show that exposing the mesothelial lining of the body cavity of mice, as a surrogate for the mesothelial lining of the chest cavity, to long multiwalled carbon nanotubes results in asbestos-like, length-dependent, pathogenic behaviour. This includes inflammation and the formation of lesions known as granulomas. This is of considerable importance, because research and business communities continue to invest heavily in carbon nanotubes for a wide range of products under the assumption that they are no more hazardous than graphite. Our results suggest the need for further research and great caution before introducing such products into the market if long-term harm is to be avoided.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Air Quality and Health Impacts
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Iijima, S. Helical microtubules of graphite carbon. Nature 354, 56–58 (1991).10.1038/354056a0 ↗
2. Tasis, D., Tagmatarchis, N., Bianco, A. & Prato, M. Chemistry of carbon nanotubes. Chem. Rev. 106, 1105–1136 (2006).10.1021/cr050569o ↗
3. Donaldson, K. et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 92, 5–22 (2006).10.1093/toxsci/kfj130 ↗
4. Royal Society and Royal Academy of Engineering. Nanoscience and nanotechnologies: opportunities and uncertainties (The Royal Society, London, 2004).
5. Thayer, A. M. Carbon nanotubes by the metric ton: Anticipating new commercial applications, producers increase capacity. Chem. Eng. News 85, 29–38 (2007).10.1021/cen-v085n046.p029 ↗
6. Holman, M. W. & Lackner, D. I. The Nanotech Report 4th edn (Lux Research, New York, 2006).
7. The risk in nanotechnology: a little risky business. The Economist Nov 22 (2007) < http://www.economist.com/displaystory.cfm?story_id=10171212 >.
8. Maynard, A. D. Nanotechnology: the next big thing, or much ado about nothing? Ann. Occup. Hyg. 51, 1–12 (2007).
9. Service, R. F. Nanotoxicology. Nanotechnology grows up. Science 304, 1732–1734 (2004).10.1126/science.304.5678.1732 ↗
10. Muller, J. et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 207, 221–231 (2005).10.1016/j.taap.2005.01.008 ↗
11. Mossman, B. T. & Churg, A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit Care Med. 157, 1666–1680 (1998).10.1164/ajrccm.157.5.9707141 ↗
12. Donaldson, K. & Tran, C. L. An introduction to the short-term toxicology of respirable industrial fibres. Mutat. Res. 553, 5–9 (2004).10.1016/j.mrfmmm.2004.06.011 ↗
13. Kane, A. B. Mechanisms of mineral fibre carcinogenesis, in Mechanisms of Fibre Carcinogenesis (ed. Kane, A. B., Boffetta, P., Saracci, R. & Wilbourn, J. D.) 11–34 (IARC, Lyon, 1996).
14. Maynard, A. D. et al. Safe handling of nanotechnology. Nature 444, 267–269 (2006).10.1038/444267a ↗
15. Warheit, D. B. et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77, 117–125 (2004).10.1093/toxsci/kfg228 ↗
16. Lam, C. W., James, J. T., McCluskey, R. & Hunter, R. L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126–134 (2004).10.1093/toxsci/kfg243 ↗
17. Shvedova, A. A. et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 289, 698–708 (2005).10.1152/ajplung.00084.2005 ↗
18. Craighead, J. E. et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch. Pathol. Lab. Med. 106, 544–596 (1982).
19. Donaldson, K., Brown, G. M., Brown, D. M., Bolton, R. E. & Davis, J. G. Inflammation generating potential of long and short fiber amosite asbestos samples. Br. J. Indust. Med. 46, 271–276 (1989).
20. Lechner, J. F. et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl Acad. Sci. USA 82, 3884–3888 (1985).10.1073/pnas.82.11.3884 ↗
21. Moalli, P. A., Macdonald, J. L., Goodglick, L. A. & Kane, A. B. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 128, 426–445 (1987).
22. Davis, J. G. et al. The pathogenicity of long versus short fiber samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br. J. Exp. Pathol. 67, 415–430 (1986).
23. Kagan, V. E. et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol. Lett. 165, 88–100 (2006)10.1016/j.toxlet.2006.02.001 ↗
24. Kamp, D. W., Graceffa, P., Pryor, W. A. & Weitzman, S. A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med. 12, 293–315 (1992).10.1016/0891-5849(92)90117-Y ↗
25. Ye, J. et al. Critical role of glass fiber length in TNF-alpha production and transcription factor activation in macrophages. Am. J. Physiol. 276, 426–434 (1999).10.1152/ajpcell.1999.276.2.C426 ↗
26. McNally, A. K. & Anderson, J. M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 147, 1487–1499 (1995).
27. Maynard, A. D. et al. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A 67, 87–107 (2004).10.1080/15287390490253688 ↗
28. World Health Organization. Determination of Airborne Fibre Number Concentrations: A Recommended Method by Phase Contrast Optical Microscopy (World Health Organization, Geneva, 1997).